295
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Primary thyroid lymphoma: survival analysis of SEER database (1995–2016)

, , &
Pages 2796-2799 | Received 06 Mar 2021, Accepted 10 May 2021, Published online: 27 May 2021

References

  • Sakorafas GH, Kokkoris P, Farley DR. Primary thyroid lymphoma (correction of lymphoma): diagnostic and therapeutic dilemmas. Surg Oncol. 2010;19(4):e124–e129.
  • Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013;98(8):3131–3138.
  • Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: incidence – SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Sub (1975–2016 varying) – linked to county attributes – total U.S., 1969–2017 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on November 2018 submission; 2019. Available from: www.seer.cancer.gov
  • Pohar Perme M, Estève J, Rachet B. Analysing population-based cancer survival – settling the controversies. BMC Cancer. 2016;16(1):933–933.
  • Derringer GA, Thompson LD, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24(5):623–639.
  • Alzouebi M, Goepel JR, Horsman JM, et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol. 2012;40(6):2075–2080.
  • International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329(14):987–994.
  • Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555–4562.
  • Thieblemont C, Cascione L, Conconi A, et al. A MALT lymphoma prognostic index. Blood. 2017;130(12):1409–1417.
  • Odejide OO, Cronin AM, Davidoff AJ, et al. Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients. Leuk Lymphoma. 2015;56(3):716–724.
  • Persky DO, Li H, Stephens DM, et al. Positron emission tomography-directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol. 2020;38(26):3003–3011.
  • Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2020;137(1):39–48.
  • Lossos IS. Stage I DLBCL: extranodal may mean extra radiation. Blood. 2021;137(1):3–5.
  • Yi J, Yi P, Wang W, et al. A multicenter retrospective study of 58 patients with primary thyroid diffuse large B cell lymphoma. Front Endocrinol (Lausanne). 2020;11:542.
  • Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21(22):4157–4164.
  • Watanabe N, Narimatsu H, Noh JY, et al. Long-term outcomes of 107 cases of primary thyroid mucosa-associated lymphoid tissue lymphoma at a single medical institution in Japan. J Clin Endocrinol Metab. 2018;103(2):732–739.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.